Robert Azelby, Director: ADC Therapeutics ADCT Sell · Filed 24/06/18

Trade details

Type: Insider sale
Amount: $20,215.55
Shares · price: 6,995 sh · $2.89 a share
Held after: 53,005 sh
Stock: ADC Therapeutics ADCT
Person: Robert AzelbyDirector
Trade date: 24/06/17
Filed: 24/06/18
Days to filing: 1 days

Sold 11.7% of holdings

Share of holding sold: 11.7%

ADC Therapeutics trades, last 26 weeks

What else happened in ADC Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/18~24/07/17

Robert Azelby's recent trades

No other trades yet.